Don’t like needles? A nasal spray for allergies could replace EpiPen
Global News
Experts say having a needle-free alternative to the EpiPen injection is 'very significant' as it gives people more options to treat their allergies and could increase uptake.
Allergy sufferers in Canada may be able to swap their EpiPen injections for a nasal spray as early as next year.
Neffy, made by drugmaker ARS Pharmaceuticals Inc., is the first epinephrine nasal spray to be approved in the United States to treat life-threatening allergic reactions known as anaphylaxis.
The U.S. Food and Drug Administration (FDA) green-lit the device on Aug. 9 for the emergency treatment of severe allergic reactions, including those that are life-threatening, in adults and older children.
Health Canada told Global News on Monday that it has not yet received a submission for Neffy, but the company says is it planning to file later this year.
“ARS anticipates filing for approval from Heath Canada by Q4 2024,” Richard Lowenthal, CEO of ARS Pharmaceuticals, said in an emailed response to Global News.
“It may take Health Canada up to 10 months to approve but hopefully sooner, so likely availability in Canada is late 2025.”
Experts say having a needle-free alternative to the EpiPen injection is “a very significant step forward” as it gives people more options to treat their allergies and could also increase uptake of epinephrine, which is the first line of treatment for anaphylaxis.
Jennifer Lake, a pharmacist and assistant professor at the University of Toronto’s Lesley Dan Faculty of Pharmacy, said allergy sufferers who have anaphylaxis have only been able to inject epinephrine in the past.
Treacherous road conditions led to several crashes on the QEII highway that forced RCMP to shut down the road between Calgary and Red Deer, where about 100 vehicles got stuck.
U.S. President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal restrictions on research for potential new medical products.
The report was released by the Manitoba Government and General Employees' Union and is based on feedback from crews and other staff involved in the wildfire fight.
Opponents of coal mining in the eastern slopes of the Rocky Mountains have some sharp criticism for Alberta's UCP government after being told to resubmit their citizens petition.
Three children in Ontario have died from influenza A-related complications since the start of December, health officials said Monday.
The company that operates the Trans Mountain pipeline has paid a $196,000 fine for environmental lapses along its B.C. pipeline route in the aftermath of a massive Jan. 2024 storm.
Alberta's provincial government has announced the creation of three new all-season resort areas that it claims could generate thousands of jobs and billions in economic benefits.
Corb Lund says he's seeking the intervention as new coal mines could threaten land and water on the eastern slopes of the Rocky Mountains and affect the Prairies downstream.
Officers had recently captured four grizzly bears, but forensic results came back to confirm that none of the bears, an adult female and three young, were linked to the attack.
The research recommends occipital nerve blocks should be offered in emergency rooms to treat acute migraine attacks.
A federal vaccine advisory committee voted on Friday to end the longstanding recommendation that all U.S. babies get the hepatitis B vaccine on the day they’re born.
Darlene Hensch, who once struggled with unexplained infertility, is now expecting quadruplets and preparing for a high-risk delivery and life-changing journey.
Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving forward.